Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Killer Cell Immunoglobulin-like Receptors and Their HLA Ligands are Related with the Immunopathology of Chagas Disease.

Ayo CM, Reis PG, Dalalio MM, Visentainer JE, Oliveira Cde F, de Araújo SM, de Oliveira Marques DS, Sell AM.

PLoS Negl Trop Dis. 2015 May 15;9(5):e0003753. doi: 10.1371/journal.pntd.0003753. eCollection 2015 May.

2.

Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis.

Salim PH, Jobim M, Bredemeier M, Chies JA, Schlottfeldt J, Brenol JC, Jobim LF, Xavier RM.

Clin Exp Immunol. 2010 Jun;160(3):325-30. doi: 10.1111/j.1365-2249.2010.04095.x. Epub 2010 Jan 15.

3.

Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.

David G, Djaoud Z, Willem C, Legrand N, Rettman P, Gagne K, Cesbron A, Retière C.

J Immunol. 2013 Nov 1;191(9):4778-88. doi: 10.4049/jimmunol.1301580. Epub 2013 Sep 27.

4.

Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.

Keating SE, Ní Chorcora C, Dring MM, Stallings RL, O'Meara A, Gardiner CM.

Tissue Antigens. 2015 Sep;86(3):172-7. doi: 10.1111/tan.12608. Epub 2015 Jul 22.

PMID:
26202659
5.

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer.

Giebel S, Boratyn-Nowicka A, Karabon L, Jedynak A, Pamula-Pilat J, Tecza K, Kula D, Kowal M, Frydecka I, Grzybowska E.

Hum Immunol. 2014 Jun;75(6):508-13. doi: 10.1016/j.humimm.2014.04.002. Epub 2014 Apr 19.

PMID:
24755350
6.

KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR GENES AND THEIR HLA-C LIGANDS IN HASHIMOTO THYROIDITIS IN A CHINESE POPULATION.

Li JT, Guo C, Li ML, Wei YQ, Hou YF, Jiao YL, Zhao YR, Sun H, Xu J, Cao MF, Feng L, Yu GN, Gao L, Liu YQ, Zhang BC, Zhao JJ, Zhang HQ.

Endocr Pract. 2016 Aug;22(8):935-40. doi: 10.4158/EP151175.OR. Epub 2016 Apr 4.

PMID:
27042744
7.

KIR2DL2 and KIR2DS2 as genetic markers to the methotrexate response in rheumatoid arthritis patients.

Velarde-de la Cruz EE, Sánchez-Hernández PE, Muñoz-Valle JF, Palafox-Sánchez CA, Ramírez-de Los Santos S, Graciano-Machuca O, García-Iglesias T, Montoya-Buelna M, Ramírez-Dueñas MG.

Immunopharmacol Immunotoxicol. 2016 Aug;38(4):303-9. doi: 10.1080/08923973.2016.1194429.

PMID:
27251940
8.

Killer immunoglobulin receptor genes and their HLA-C ligand are associated with Type 1 diabetes in an Eastern Indian population.

Sanjeevi S, Sun C, Kanungo A, Sanjeevi CB.

Diabet Med. 2016 Jan;33(1):91-6. doi: 10.1111/dme.12815. Epub 2015 Jul 2.

PMID:
26031759
9.

The investigation of killer cell immunoglobulin-like receptor genotyping in patients with systemic lupus erytematosus and systemic sclerosis.

Tozkır JD, Tozkır H, Gürkan H, Dönmez S, Eker D, Pamuk GE, Pamuk ÖN.

Clin Rheumatol. 2016 Apr;35(4):919-25. doi: 10.1007/s10067-016-3222-0. Epub 2016 Mar 9.

PMID:
26960450
10.

Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.

Naumova E, Mihaylova A, Stoitchkov K, Ivanova M, Quin L, Toneva M.

Cancer Immunol Immunother. 2005 Feb;54(2):172-8. Epub 2004 Jul 10.

PMID:
15248031
11.

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.

Middleton D, Diler AS, Meenagh A, Sleator C, Gourraud PA.

Tissue Antigens. 2009 Jun;73(6):553-60. doi: 10.1111/j.1399-0039.2009.01235.x.

PMID:
19493232
12.

Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibility.

Bossi G, Mannarino S, Pietrogrande MC, Salice P, Dellepiane RM, Cremaschi AL, Corana G, Tozzo A, Capittini C, De Silvestri A, Tinelli C, Pasi A, Martinetti M.

Genes Immun. 2015 Oct;16(7):481-7. doi: 10.1038/gene.2015.34. Epub 2015 Sep 3.

PMID:
26335810
13.

Killer immunoglobulin-like receptor and human leukocyte antigen-C genotypes in rheumatoid arthritis primary responders and non-responders to anti-TNF-α therapy.

McGeough CM, Berrar D, Wright G, Mathews C, Gilmore P, Cunningham RT, Bjourson AJ.

Rheumatol Int. 2012 Jun;32(6):1647-53. doi: 10.1007/s00296-011-1838-6. Epub 2011 Mar 4.

14.

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

Shastry A, Sedimbi SK, Rajalingam R, Nikitina-Zake L, Rumba I, Wigzell H, Sanjeevi CB.

Int J Immunogenet. 2008 Dec;35(6):439-46. doi: 10.1111/j.1744-313X.2008.00804.x.

PMID:
19046302
15.

Killer-cell immunoglobulin-like receptor gene polymorphisms and susceptibility to psoriatic arthritis.

Chandran V, Bull SB, Pellett FJ, Ayearst R, Pollock RA, Gladman DD.

Rheumatology (Oxford). 2014 Feb;53(2):233-9. doi: 10.1093/rheumatology/ket296. Epub 2013 Oct 31.

PMID:
24185760
16.

Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.

Littera R, Chessa L, Onali S, Figorilli F, Lai S, Secci L, La Nasa G, Caocci G, Arras M, Melis M, Cappellini S, Balestrieri C, Serra G, Conti M, Zolfino T, Casale M, Casu S, Pasetto MC, Barca L, Salustro C, Matta L, Scioscia R, Zamboni F, Faa G, Orrù S, Carcassi C.

PLoS One. 2016 Jan 8;11(1):e0146086. doi: 10.1371/journal.pone.0146086. eCollection 2016.

17.

KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a Polish Caucasian population.

Wiśniewski A, Jankowska R, Passowicz-Muszyńska E, Wiśniewska E, Majorczyk E, Nowak I, Frydecka I, Kuśnierczyk P.

Hum Immunol. 2012 Sep;73(9):927-31. doi: 10.1016/j.humimm.2012.07.323. Epub 2012 Jul 23.

PMID:
22836042
18.

Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand.

Hollenbach JA, Ladner MB, Saeteurn K, Taylor KD, Mei L, Haritunians T, McGovern DP, Erlich HA, Rotter JI, Trachtenberg EA.

Immunogenetics. 2009 Oct;61(10):663-71. doi: 10.1007/s00251-009-0396-5. Epub 2009 Sep 30.

19.

Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients.

Askar M, Avery R, Corey R, Lopez R, Thomas D, Pidwell D, Eghtesad B, Miller C, Fung J, Zein NN.

Liver Transpl. 2009 Nov;15(11):1557-63. doi: 10.1002/lt.21878.

20.

KIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan.

Nozawa Y, Umemura T, Joshita S, Katsuyama Y, Shibata S, Kimura T, Morita S, Komatsu M, Matsumoto A, Tanaka E, Ota M.

PLoS One. 2013 Dec 12;8(12):e83381. doi: 10.1371/journal.pone.0083381. eCollection 2013.

Supplemental Content

Support Center